DEMERX

DemeRx is a clinical stage drug development company advancing a new chemical entity for the treatment of alcohol use disorder... Welcome to DemeRx. We are a clinical-stage biopharmaceutical company dedicated to transforming the treatment of addiction... Our focus is on developing DMX-1001 (oral noribogaine), a promising investigational therapy for alcohol use disorder, which affects over 29 million people in the U.S.

Also known as: DemeRx Inc, DemeRx NB, DemeRx NB Inc.

Primary location: Miami United States